Andrea Camerini

2.3k total citations
73 papers, 1.2k citations indexed

About

Andrea Camerini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Andrea Camerini has authored 73 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 44 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Andrea Camerini's work include Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Research Studies (20 papers) and Lung Cancer Diagnosis and Treatment (15 papers). Andrea Camerini is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Research Studies (20 papers) and Lung Cancer Diagnosis and Treatment (15 papers). Andrea Camerini collaborates with scholars based in Italy, Spain and France. Andrea Camerini's co-authors include Alessandro Sgambato, Achille Cittadini, D. Amoroso, Beatrice Faraglia, Marcello Tiseo, Sara Donati, Editta Baldini, Giulio Rossi, C. Puccetti and Mario Migaldi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal Of Pathology.

In The Last Decade

Andrea Camerini

66 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Camerini Italy 22 691 524 493 269 174 73 1.2k
Derya Duranyıldız Türkiye 22 662 1.0× 234 0.4× 603 1.2× 294 1.1× 121 0.7× 85 1.4k
Zhenhua Zhai China 14 484 0.7× 251 0.5× 685 1.4× 356 1.3× 77 0.4× 22 1.4k
Satoru Moriyama Japan 24 574 0.8× 486 0.9× 929 1.9× 245 0.9× 129 0.7× 82 1.7k
Isabelle Valo France 16 381 0.6× 462 0.9× 311 0.6× 211 0.8× 67 0.4× 34 1.0k
Yun Jung Choi South Korea 18 530 0.8× 349 0.7× 751 1.5× 372 1.4× 100 0.6× 45 1.4k
Kenji Tsuchihashi Japan 18 625 0.9× 283 0.5× 655 1.3× 314 1.2× 67 0.4× 69 1.4k
Katharina König Germany 14 357 0.5× 231 0.4× 564 1.1× 246 0.9× 121 0.7× 20 1.0k
Takuro Kometani Japan 16 624 0.9× 600 1.1× 555 1.1× 178 0.7× 63 0.4× 43 1.2k
Guichun Huang China 24 655 0.9× 239 0.5× 959 1.9× 636 2.4× 91 0.5× 53 1.7k

Countries citing papers authored by Andrea Camerini

Since Specialization
Citations

This map shows the geographic impact of Andrea Camerini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Camerini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Camerini more than expected).

Fields of papers citing papers by Andrea Camerini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Camerini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Camerini. The network helps show where Andrea Camerini may publish in the future.

Co-authorship network of co-authors of Andrea Camerini

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Camerini. A scholar is included among the top collaborators of Andrea Camerini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Camerini. Andrea Camerini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tarantini, Luigi, Giuseppina Gallucci, Alessandro Inno, et al.. (2025). A New Era, New Risks: The Cardio-Oncology Perspective on Immunotherapy in Non-Small Cell Lung Cancer. Cancers. 17(21). 3443–3443.
2.
Camerini, Andrea, Francesca Mazzoni, Vieri Scotti, et al.. (2024). Efficacy and Safety of Chemotherapy after Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Medicine. 13(13). 3642–3642. 3 indexed citations
3.
Canale, Maria Laura, Giancarlo Casolo, Sara Donati, et al.. (2023). Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab. In Vivo. 37(5). 2139–2146.
4.
Canale, Maria Laura, Andrea Camerini, Francesco Orso, et al.. (2022). Modello organizzativo e di un percorso clinico per la gestione cardiologica ambulatoriale del paziente oncologico: una proposta congiunta ANMCO e AIOM Toscana. Giornale italiano di cardiologia. 23(6). 437–443.
5.
6.
Canale, Maria Laura, Andrea Camerini, Giancarlo Casolo, et al.. (2020). Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy. Advances in Therapy. 37(7). 3178–3184. 31 indexed citations
7.
Tibaldi, Carmelo, Andrea Camerini, Marcello Tiseo, et al.. (2018). Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study. British Journal of Cancer. 119(11). 1326–1331. 13 indexed citations
8.
Canale, Maria Laura, et al.. (2017). Invasione diretta dell’aorta ascendente da tumore del polmone evidenziata da risonanza magnetica. Giornale italiano di cardiologia. 18(4). 329–330. 1 indexed citations
9.
Canale, Maria Laura, Andrea Camerini, Jacopo Del Meglio, et al.. (2017). Applicazione di un percorso diagnostico-terapeutico assistenziale di cardioncologia per la rilevazione e la gestione del danno cardiaco da trattamenti oncologici in ambito ospedaliero. Giornale italiano di cardiologia. 18(11). 760–763.
10.
Mencoboni, Manlio, Rosangela Filiberti, Alessandro Del Conte, et al.. (2017). Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC. Anticancer Research. 37(6). 3189–3194. 23 indexed citations
11.
12.
Giorgi, Ugo De, Karim Rihawi, Michele Aieta, et al.. (2014). Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer. Journal of Geriatric Oncology. 5(2). 156–163. 22 indexed citations
13.
Mazzoni, Francesca, Fabiana Letizia Cecere, Luca Boni, et al.. (2013). Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer. Lung Cancer. 82(2). 288–293. 30 indexed citations
14.
Tiseo, Marcello, Elisa Giovannetti, Carmelo Tibaldi, et al.. (2012). Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed–carboplatin. Lung Cancer. 78(1). 92–99. 33 indexed citations
15.
Camerini, Andrea, Sara Donati, Paolo Viacava, et al.. (2011). Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer. Journal of Experimental & Clinical Cancer Research. 30(1). 38–38. 13 indexed citations
16.
Sgambato, Alessandro, Andrea Camerini, Giannicola Genovese, et al.. (2010). Loss of nuclear p27kip1 and α‐dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma. Cancer Science. 101(9). 2080–2086. 21 indexed citations
17.
Sgambato, Alessandro, Andrea Camerini, Paola Collecchi, et al.. (2009). Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin‐based chemotherapy. Cancer Science. 100(6). 1026–1033. 14 indexed citations
18.
Camerini, Andrea, C. Valsuani, Francesca Mazzoni, et al.. (2009). Phase II trial of single-agent oral vinorelbine in elderly (≥70 years) patients with advanced non-small-cell lung cancer and poor performance status. Annals of Oncology. 21(6). 1290–1295. 18 indexed citations
19.
Sgambato, Alessandro, Gian Franco Zannoni, Beatrice Faraglia, et al.. (2004). Decreased expression of the CDK inhibitor p27Kip1 and increased oxidative DNA damage in the multistep process of cervical carcinogenesis. Gynecologic Oncology. 92(3). 776–783. 24 indexed citations
20.
Sgambato, Alessandro, Andrea Camerini, Beatrice Faraglia, et al.. (2004). Targeted inhibition of the epidermal growth factor receptor‐tyrosine kinase by ZD1839 (‘Iressa’) induces cell‐cycle arrest and inhibits proliferation in prostate cancer cells. Journal of Cellular Physiology. 201(1). 97–105. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Derya Duranyıldız Breakdown of academic impact, for papers by Zhenhua Zhai Breakdown of academic impact, for papers by Satoru Moriyama Breakdown of academic impact, for papers by Isabelle Valo Breakdown of academic impact, for papers by Yun Jung Choi Breakdown of academic impact, for papers by Kenji Tsuchihashi Breakdown of academic impact, for papers by Katharina König Breakdown of academic impact, for papers by Takuro Kometani Breakdown of academic impact, for papers by Guichun Huang
Rankless by CCL
2026